These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 34799280)

  • 1. Public healthcare expenditure and COVID-19 mortality in Spain and in Europe. Response to the Letter from the Editor by Velasco Montes et al.
    Elola-Somoza FJ; Bas-Villalobos MC; Pérez-Villacastín J; Macaya-Miguel C
    Rev Clin Esp (Barc); 2022 Jan; 222(1):56-57. PubMed ID: 34799280
    [No Abstract]   [Full Text] [Related]  

  • 2. [Public healthcare expenditure and COVID-19 mortality in Spain and in Europe. Response to the Letter from the Editor by Velasco Montes et al].
    Elola-Somoza FJ; Bas-Villalobos MC; Pérez-Villacastín J; Macaya-Miguel C
    Rev Clin Esp; 2022 Jan; 222(1):56-57. PubMed ID: 34565823
    [No Abstract]   [Full Text] [Related]  

  • 3. On public healthcare expenditure and COVID-19 mortality in Spain and in Europe.
    Velasco Montes J; González Díez S; Rivas Cilleros E
    Rev Clin Esp (Barc); 2022 Jan; 222(1):56. PubMed ID: 34799279
    [No Abstract]   [Full Text] [Related]  

  • 4. Public healthcare expenditure and COVID-19 mortality in Spain and in Europe.
    Elola-Somoza FJ; Bas-Villalobos MC; Pérez-Villacastín J; Macaya-Miguel C
    Rev Clin Esp (Barc); 2021; 221(7):400-403. PubMed ID: 34049840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mortality by COVID-19 in Spain. Approximation through public health expenditure by autonomous communities.].
    Ramón-Dangla R; Rico-Gómez ML; Issa-Khozouz R
    Rev Esp Salud Publica; 2021 Mar; 95():. PubMed ID: 33664220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Letter to the editor: Excess all-cause mortality during second wave of COVID-19 - the Polish perspective.
    Grabowski J; Witkowska N; Bidzan L
    Euro Surveill; 2021 Feb; 26(7):. PubMed ID: 33602384
    [No Abstract]   [Full Text] [Related]  

  • 7. Let's leverage SARS-CoV2 vaccination to screen for hepatitis C in Spain, in Europe, around the world.
    Crespo J; Lazarus JV; Iruzubieta P; García F; García-Samaniego J;
    J Hepatol; 2021 Jul; 75(1):224-226. PubMed ID: 33757805
    [No Abstract]   [Full Text] [Related]  

  • 8. Letter to the Editor: THE IMPACT OF THE COVID-19 PANDEMIC ON SCHIZOPHRENIA PATIENTS.
    Hoşgelen EI; Alptekin K
    Turk Psikiyatri Derg; 2021; 32(3):219-221. PubMed ID: 34637131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Letter #1 Response to letter to Editor by Dr. Sarkar et al. for' who said differentiating preeclampsia from COVID-19 infection was easy? Refers to PII: S2210-7789(21)00539-0 Letter #2 Response to letter to Editor by Dr. Hantoushzadeh et al. for' is COVID-19 disease a risk factor for preeclampsia? Should aspirin be considered for prophylaxis of preeclampsia in these patients?' Refers to PII: S2210-7789(21)00538-9.
    Jayaram A; Buhimschi IA; Buhimschi CS
    Pregnancy Hypertens; 2022 Mar; 27():94-95. PubMed ID: 34973599
    [No Abstract]   [Full Text] [Related]  

  • 10. Response to the letter to the editor: A comment on C-reactive protein and SOFA scale: a simple scale as an early predictor of the need for critical care in patients with COVID-19 pneumonia in Spain.
    Vaquero Roncero LM; Sánchez Barrado E; Sánchez Hernández MV
    Rev Esp Anestesiol Reanim (Engl Ed); 2022; 69(7):442-443. PubMed ID: 35869008
    [No Abstract]   [Full Text] [Related]  

  • 11. Early Interventions and Impact of COVID-19 in Spain.
    Alfonso Viguria U; Casamitjana N
    Int J Environ Res Public Health; 2021 Apr; 18(8):. PubMed ID: 33921238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Letter to the Editor Regarding Torres-Costa et al "SARS-CoV-2 in Ophtalmology: Current Evidence and Recommendations for Clinical Practice"].
    Martins TGDS
    Acta Med Port; 2021 Jan; 34(1):63. PubMed ID: 33092689
    [No Abstract]   [Full Text] [Related]  

  • 13. The COVID-19 Pandemic in Spain: Experiences of Midwives on the Healthcare Frontline.
    Goberna-Tricas J; Biurrun-Garrido A; Perelló-Iñiguez C; Rodríguez-Garrido P
    Int J Environ Res Public Health; 2021 Jun; 18(12):. PubMed ID: 34204286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations of BNT162b2 vaccination with SARS-CoV-2 infection and hospital admission and death with covid-19 in nursing homes and healthcare workers in Catalonia: prospective cohort study.
    Cabezas C; Coma E; Mora-Fernandez N; Li X; Martinez-Marcos M; Fina F; Fabregas M; Hermosilla E; Jover A; Contel JC; Lejardi Y; Enfedaque B; Argimon JM; Medina-Peralta M; Prieto-Alhambra D
    BMJ; 2021 Aug; 374():n1868. PubMed ID: 34407952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-COV-2 seroprevalence among all healthcare workers in a tertiary hospital in Spain.
    Cantero M; Millán-Pérez R; Muñez E; Gómez-Lozano N; Anel-Pedroche J; Parra LM; Rodríguez ML; Asensio A
    Infect Dis (Lond); 2022 Jan; 54(1):8-15. PubMed ID: 34424122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response to Letter to the Editor From Viola et al: "Calcifediol Treatment and COVID-19-related Outcomes".
    Nogues X; Quesada-Gomez JM; Garcia-Giralt N
    J Clin Endocrinol Metab; 2021 Nov; 106(12):e5281-e5282. PubMed ID: 34331760
    [No Abstract]   [Full Text] [Related]  

  • 17. Emerging pulmonary histopathological findings in COVID-19 patients- a letter to the editor in response to Grosse et al. 2020.
    Parmar D; Ponnampalam J; Seligmann G; Gandhi T
    Cardiovasc Pathol; 2021; 51():107302. PubMed ID: 33152459
    [No Abstract]   [Full Text] [Related]  

  • 18. No Role for Reintroducing OPV into the United States with Respect to Controlling COVID-19 [Response to the letter to the Editor by Chumakov et al.].
    Thompson KM; Kalkowska DA; Badizadegan K
    Risk Anal; 2021 Feb; 41(2):389-392. PubMed ID: 33590518
    [No Abstract]   [Full Text] [Related]  

  • 19. Phylogeography of SARS-CoV-2 pandemic in Spain: a story of multiple introductions, micro-geographic stratification, founder effects, and super-spreaders.
    Gómez-Carballa A; Bello X; Pardo-Seco J; Pérez Del Molino ML; Martinón-Torres F; Salas A
    Zool Res; 2020 Nov; 41(6):605-620. PubMed ID: 32935498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Letter to the Editor in Response to Khazanchi et al.
    Nayak A; Islam SJ; Mehta A; Quyyumi AA
    J Gen Intern Med; 2021 Apr; 36(4):1113-1114. PubMed ID: 33469749
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.